CWF19L1

Across TCGA pan-cancer cohorts, CWF19L1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CWF19L1 data layer compared with 21 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CWF19L1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CWF19L1 expression acts as an unfavorable survival marker, although some lineages such as LSCC and LUAD show a favorable association.

COAD, LSCC, and LUAD are the cancer types where CWF19L1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	IV	0.493	0.944	.031	18	view →
LSCC	DFS	Median	II,III,IV	1.000	0.419	.008	8	view →
LUAD	DFS	Median	All	0.967	0.833	.011	1	view →
PDAC	DFS	Median	III,IV	0.488	0.940	.024	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CWF19L1–COAD (DFS)

Open the COAD breakdown →